Hidden Signals
Decisive Answers
The Explainable AI team for Early-Stage Drug Development
1
Explainable By design
Logical AI generating explicit, auditable hypotheses - not black-box predictions. Every insight can be scrutinized, validated, and defended.
2
Small N, High-Dimensional
Particularly compelling for 4-70 patients with multi-omics and heterogeneous clinical data. We thrive where others give up.
.png)
3
Data-Agnostic + Domain Expert
Logic-based technology augmented by deep scientific expertise across neuroscience, oncology, immunology, and rare disease.
4
Human-in-the-Loop
KEM® augments Ariana's expert data scientists - and your team. Technology without domain knowledge is just noise.
.png)
5
Multi-Modal Data Ready
Clinical, multi-omics, immune profiling, neuroimaging, digital biomarkers, RWE - all in. We handle heterogeneity as a feature, not a bug.
6
Iterative, Co-Created Process
KEM® + Ariana team + your team - working in cycles to generate increasingly compelling and defensible biological results.
Particularly powerful for cohorts of 4-70 patients with high-dimensional, multi-omics, and heterogeneous clinical data.
Where standard models fail, KEM® finds signal.
Meet KEM®
Our Explainable AI Platform
Therapeutic Areas
Neuroscience
Oncology
Immunology
Rare Disease
Inflammatory
Infectious Disease
Auto-immune
Metabolic Disease
Vaccines
OUR CLIENTS
For over two decades, Ariana has partnered with leading pharmaceutical and biotechnology organizations across complex therapeutic areas.
For over two decades, Ariana has partnered with leading pharmaceutical and biotechnology organizations across complex therapeutic areas.
Ariana Pharma provides a high level of transparency, which is essential for meaningful translational research.
Makoto MIYARA, MD, PHD
Professor of Immunology & Hospital Practitioner, Pitié-Salpêtrière AP-HP Hospital